tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook for Monopar Therapeutics’ ALXN1840 Amid New Copper Balance Findings
PremiumRatingsPositive Outlook for Monopar Therapeutics’ ALXN1840 Amid New Copper Balance Findings
8d ago
Monopar Therapeutics price target raised to $104 from $87 at BTIG
Premium
The Fly
Monopar Therapeutics price target raised to $104 from $87 at BTIG
8d ago
Monopar jumps after doctor letter in Journal of Hepatology
Premium
The Fly
Monopar jumps after doctor letter in Journal of Hepatology
9d ago
Promising Long-Term Efficacy and Safety of ALXN1840 Strengthens Buy Rating for Monopar Therapeutics Inc.
PremiumRatingsPromising Long-Term Efficacy and Safety of ALXN1840 Strengthens Buy Rating for Monopar Therapeutics Inc.
17d ago
Monopar Therapeutics Presents New Data on ALXN1840
Premium
Company Announcements
Monopar Therapeutics Presents New Data on ALXN1840
18d ago
Monopar Therapeutics Inc’s ALXN1840: A Promising Breakthrough in Wilson Disease Treatment Justifying Buy Rating
Premium
Ratings
Monopar Therapeutics Inc’s ALXN1840: A Promising Breakthrough in Wilson Disease Treatment Justifying Buy Rating
18d ago
Monopar Therapeutics initiated with a Strong Buy at Raymond James
PremiumThe FlyMonopar Therapeutics initiated with a Strong Buy at Raymond James
1M ago
Monopar Therapeutics files $300M mixed securities shelf
Premium
The Fly
Monopar Therapeutics files $300M mixed securities shelf
1M ago
Monopar Therapeutics assumed with a Buy at H.C. Wainwright
Premium
The Fly
Monopar Therapeutics assumed with a Buy at H.C. Wainwright
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100